Correction: Hu, W., et al. Targeting Dopamine Receptor D2 by Imipridone Suppresses Uterine Serous Cancer Malignant Phenotype. Cancers 2020, 12, 2436

類似資料

• Targeting Dopamine Receptor D2 by Imipridone Suppresses Uterine Serous Cancer Malignant Phenotype
  著者:: Hu, Wen, 等
  出版事項: (2020)
• EXTH-70. CYP450 AND METABOLIC PROFILING OF ANTI-CANCER IMIPRIDONE ONC201
  著者:: Morrow, Sara, 等
  出版事項: (2020)
• Ubiquitin Carboxyl-Terminal Hydrolase L1 (UCHL1) Promotes Uterine Serous Cancer Cell Proliferation and Cell Cycle Progression
  著者:: Kwan, Suet-Ying, 等
  出版事項: (2020)
• ONC201 and imipridones: Anti-cancer compounds with clinical efficacy
  著者:: Prabhu, Varun Vijay, 等
  出版事項: (2020)
• CAF reprogramming inhibits ovarian cancer progression
  著者:: Yeung, Tsz-Lun, 等
  出版事項: (2014)